Synthesis, Characterization and Antibacterial Mechanism of Action of (Fluoro) Quinolones: An Overview
DOI:
https://doi.org/10.14738/aivp.111.13177Abstract
Quinolones are used to treat bacterial infections. Given their good tolerance and demonstrated activity, fluoroquinolones are widely prescribed. This wide use has unfortunately led to bacterial resistance increase. Many efforts have been made to develop new fluoroquinolone antibiotics. However, new and more effective derivatives need to be investigated. This is an overview of studies done these last decades, on fluoroquinolone synthesis, their characterization and their mechanism of actions.
References
Abdou M. M. Chemistry of 4-Hydroxy-2-(1H)-quinolone. Part 1: Synthesis and reactions. Arabian Journal of Chemistry. 2017, 10 (2): S3324-37. DOI : https://doi.org/10.1016/j.arabjc.2014.01.012.
George Y. L., Ernest J. F., Monte D. G., John Hays. B. and R. Pauline. B. 1,8-Naphtyridine derivatives. A new class of chemotherapeutic agents. Journal of Medicinal and Pharmaceutical Chemistry. 1962, 5 (5) : 1063-5 ; https://doi.org/10.1021/jm01240a021
Hooper D. C and Jocoby G. A. Mechanisms of drug resistance: quinolone resistance. Ann. N. Y. Sci. 2015; 1354:12-31; DOI: 10.1111/nyas.12830
Hooper D. C and Jacoby G. A. Topoisomerase Inhibitors: Fluoroquinolones Mechanisms of Action and Resistance. Cold Spring Harb Perspect Med 2016 ; 6 : a025320 ; DOI : 10.1101/cshperspect.a025320 215
Rama K., Vishal S., Gopal N., Satish K. A., Alka Al. Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents. European Journal of Medicinal Chemistry. 2016, Volume 124 (29) : 218-28 ; https://doi.org/10.1016/j.ejmech.2016.08.031
Abdou M. M. Chemistry of 4-Hydroxy-2(1H)-quinolone. Part 2. As synthons in heterocyclic synthesis. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabajc.2014.11.021
Heeb S., Fletcher M. P., Chhabra S. R., Diggle S. P., William P and Camara M. Quinolones: from antibiotics to autoinducers (Review article). FEMS Microbiol. Rev. 2011;35:247-74; DOI: 10.1111/j.1574-6976.2010.00247.x
Gledraitiené A., Vitkausklené A., Naginiené R., Pavilonis A. Antibiotic Resistance Mechanisms of Clinically Important Bacteria. Medicina (Kaunas) 2011 ; 47(3) :137-46 ; https://doi.org/10.3390/medicina47030019
Namboodri S. S., Opintan J. A., Lijek R. S., Newman M. J., Okeke I. N. Quinolone resistance in Escherichia coli from Accra, Ghana. B. M. C. Microbio. 2011; 11(44):1-9; http://www.biomedcentral.com/1471-2180/11/44
Blondeau J. M. Fluoroquinolones: Mechanism of Action, Classification, and Development of Resistance. Survey of Ophthalmology 2004 ; 49(2) :S73-8 ; DOI : 10.1016/j.survophthal.2004.01.005
Fabrega A., Madurga S., Giralt E and Vila J. Mechanism of action of and resistance to quinolones. Microb. Biotech. 2009 ; 2(1) :40-61 ; DOI : 10.1111/j.1751-7915.2008.00063.x
Zhang G., Liu X., Zhang S., Pan B., Liu M. Ciprofloxacin derivatives and their antibacterial activities. Eur. J. Med. Chem. 2018;146:599-612; https://doi.org/10.1016/j.ejmech.2018.01.078
Hernandez. A., Sanchez M. B and Martinez J. Quinolone resistance: much more than predicted. Front. Microbiol. 2011; 2(22):1-6; DOI: 10.3389/fmicb.2011.00022
Schwanz H. A. Structural features of fluoroquinolone-class antibiotics that affect lethal and DNA binding. Thesis and Dissertation 2012 Iowa Research Online University of Iowa pp 206
Dirlica K., Malik M., Kerns R. J. and Zhao X. Quinolone-Mediated Bacterial Death (Minireview). Anticrob. Ag. Chemth. 2008 ; 52(2) :385-92 ; DOI : 10.1128/AAC.01617.06
Morales-Cid G., Feketen A., Simonet B. M., Lehmann R., Cẚrdenas S., Zhang X., Valcẚrcel M and Schimitt-Kopplin P. In Situ Synthesis of Magnetic Multiwalled Carbon Nanotube Composites for the Clean-up of (Fluoro) Quinolones from Human Plasma Prior to Ultrahigh Pressure Liquid Chromatography Analysis. Anal. Chem. 2010;82(7):2743-52; DOI:10.102/ac902631h
Junza A., Amatya R., Barron D., Barbosa. Comparative study of the LC-MS/MS and UPLC-MS/MS for the multiresidue analysis of quinolones, penicillin and cephalosporins in cow milk, and validation according to the regulation 2002/657/EC. J. Chrom. B. 2011; 879:2601-10; DOI: 10.1016/jchromb2011.07018
Aldred K. J., Kerns R. J., Osheroff N. Mechanism of Quinolone Action and Resistance. Biochemistry 2014, 53(10) :1565-74. DOI : 10. 1021/bi5000564
Flavia S., James T. H., Laura C., Stephen M. G., Warren R. J. D. G., Martin W., and David R. S. The Synthesis of Quinolone Natural Products from Pseudonocardia sp. European Journal of Organic Chemistry. 2016, 2016 (3) : 434–7 ; DOI: 10.1002/ejoc.201501400
Kumar N., Dhamija I., Raj P. V., Jayashree B. S., Parihar V., Manjula S. N., Thomas S., Kutty N. G., Rao C. M. Preliminary investigatigation of cytotoxic potential of 2-quinolone derivatives using in vitro and in vivo (solid tumor and liquid tumor) models of cancer. Arab. J. Chem. 2014;7:409-17 ; http://dx.doi.org/10.1016/j.arabjc.2012.12.029 216
Sharma P. C., Jain A., Yar M. S., Pahwa R., Singh J and Chanadstitia P. Novel fluoroquinolone derivatives bearing N-thiomide with 6-substituted-2-aminobenzothiazoles: Synthesis and antibacterial evaluation. Ara. J. Chem. 2017;10:S568-75; http://dx.doi.org/10.1016/j.arabjc.2012.11.002
Lucia P. Quinolones: Synthesis and Antibacterial Activity. In Antimicrobial Agents. IntechOpen. 2012; 12:255-72.
Winter R. W., Kelly J. X., Smilkstein M. J., Dodean R., Hinrichs D. and Riscoe M. K. Antimalarial Quinolones: Synthesis, potency, and mechanistic studies. Exp. Parasitol. 2008; 118(4):487-97
Wube A. A., Hufner A., Thomaschitz C., Blunder M., Kollroser M., Bauer R., Bucar F. Design, synthesis and antimycobacterial activities of 1-methyl-2-alkenyl-4(1H)-quinolones. Bioorg. Med. Chem. 2011; 19:567-79; DOI:10.1016/bmc.2010.10.060
Wube A. A., Bacar F., Hochfellner C., Blunder M., Bauer R. Hufner A. Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone derivatives as antimycobacterial agents against non-tubercular mycobacteria. Eur. J. Med. Chem. 2011;46:2091-101; DOI:10.1016/j.ejmech.2011.02.062
Jacoby G. A., Strahilevitz J. Hooper D. C. Plasmid-Mediated Quinolone Resistance. Micobio. Spectr. 2013; 2(5):1-24; DOI: 10.1128/mcrobiolspec.PLAS-0006-2013
Jardosh H. H., Patel M. P. Antimicrobial and antioxidant evaluation of new quinolone based aurone analogs. Arab. J. Chem. 2017; 10:S3781-9; http://dx.doi.org/10.1016/j.arabjc.2014.05.014
Chen J., Lu N., Shen X., Tang Q., Zhag C., Xu J., Sun Y., Huang X., Xu Z and Lei H. Investigation of an Immunoassay with Broad Specificity to Quinolone Drugs by Genetic Algorithm with Linear Assignment of Hypermolecular Alignment of Data Sets and Advanced Quantitative Structure-Activity Relationship Analysis. J. Agric. Food. Chem. 2016 ; 64 :2772-9 ; DOI : 10.1021/acs.jafc.6b0039
Berning M., Krasz S and Miehlke S. Should quinolones come first in Helicobacter pylori therapy ? Ther. Adv. Gastroenterol. 2011,4(2) :103-14. DOI : 10.1177/1756283X10384171
Boteva A. A. and Krasnykh O. P. THE METHODS OF SYNTHESIS, MODIFICATION, AND BIOLOGICAL ACTIVITY OF 4-QUINOLONES (REVIEW). Chemistry of Heterocyclic Compounds, 2009 ; 45(7) :757-89 ; https://doi.org/10.1007/s10593-009-0360-1
Leekha S., Terrell C. L and Edson R. S. General Principles of Antimicrobial Therapy. Mayo. Clin. Proc. 2011; 86(2):156-67; DOI: 10.4065/mcp.2010.0639
Barlow A. M. Nalidixic Acid In Infections Of Urinary Tract. Br. Med. J. 1963, 23 ; 2 (5368) : 1308-10 ; doi:10.1136/bmj.2.5368.1308
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Blaise DACKOUO
This work is licensed under a Creative Commons Attribution 4.0 International License.
